Skip to main content

Table 1 Proportion of B cells and its subpopulations (%) as detected by multicolor flow cytometry in 75 DLBCL patients bone marrow (N = 47) and peripheral blood (N = 54) samples at the time of diagnosis

From: High proportion of anergic B cells in the bone marrow defined phenotypically by CD21(−/low)/CD38- expression predicts poor survival in diffuse large B cell lymphoma

    Bone marrow Peripheral blood
Gated on Cell population Phenotype N Mean SD Min. Max. N Mean SD Min. Max.
%lymphocytes B cells CD19+ 47 13.35 7.49 0.30 32.50 54 14.11 11.71 1.79 60.00
%lymphocytes Memory CD19+ CD27+   3.60 4.71 0.04 23.40   3.29 3.83 0.00 22.70
%B cells lambda lambda+   27.27 14.47 0.52 84.90   34.65 16.25 0.82 93.30
  kappa kappa+   42.77 17.78 1.13 76.10   47.24 16.47 0.56 74.70
  Precursor CD34+ CD10+   1.40 2.34 0.00 11.00   0.41 1.05 0.00 6.36
  Transitional-e CD34- CD10+   6.73 12.95 0.00 50.80   0.07 0.13 0.00 0.62
  Transitional-d CD21- CD38+   22.53 20.80 0.35 90.10   11.34 17.86 0.00 96.90
  Transitional-a CD10+ CD38+   9.64 15.03 0.00 71.10   0.68 1.13 0.00 4.81
  Anergic CD21(−/low)CD38-   24.21 26.20 2.35 97.20   21.63 16.61 0.60 95.50
  1. DLBCL Diffuse large B cell lymphoma